These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3149335)

  • 1. [Diagnostic criteria in post-transfusion non-A, non-B hepatitis].
    Katayama T
    Nihon Rinsho; 1988 Dec; 46(12):2635-8. PubMed ID: 3149335
    [No Abstract]   [Full Text] [Related]  

  • 2. [Post-transfusion acute non-A, non-B hepatitis].
    Iwabuchi S; Fukui S; Sugai J
    Nihon Rinsho; 1988 Dec; 46(12):2663-8. PubMed ID: 3149340
    [No Abstract]   [Full Text] [Related]  

  • 3. Posttransfusion hepatitis: clinical features, risk and donor testing.
    Alter HJ
    Prog Clin Biol Res; 1985; 182():47-61. PubMed ID: 3929262
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors.
    N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-transfusion viral hepatitis and the TTVS.
    Holland PV; Bancroft W; Zimmerman H
    N Engl J Med; 1981 Apr; 304(17):1033-5. PubMed ID: 6782483
    [No Abstract]   [Full Text] [Related]  

  • 6. [Post-transfusional non-A, non-B hepatitis].
    Habibi
    Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):63-70. PubMed ID: 3149551
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.
    Aach RD; Szmuness W; Mosley JW; Hollinger FB; Kahn RA; Stevens CE; Edwards VM; Werch J
    N Engl J Med; 1981 Apr; 304(17):989-94. PubMed ID: 6782484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of post-transfusion viral hepatitis of the non-A, non-B type].
    Knap J; Karwowska S
    Pol Tyg Lek; 1982 Oct; 37(40):1209-10. PubMed ID: 6819554
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic non-A, non-B hepatitis.
    Hoofnagle JH; Alter HJ
    Prog Clin Biol Res; 1985; 182():63-9. PubMed ID: 3929263
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical picture and outcomes of post-transfusion viral hepatitis non-A, non-B and B].
    Favorov MO; Bugaeva NP; Ketiladze ES
    Sov Med; 1985; (6):97-100. PubMed ID: 3933126
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis].
    Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M
    Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897
    [No Abstract]   [Full Text] [Related]  

  • 12. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-transfusion hepatitis: analysis of risk factors.
    Aach RD; Hollinger FB; Szmuness W; Mosley JW; Gitnick GL; Kahn RA; Stevens CE; Goodwin D; Weiner JM
    Acta Haematol Pol; 1980; 11(3):159-64. PubMed ID: 6778053
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion-associated hepatitis C virus (non-A, non-B) infection.
    Polesky HF; Hanson MR
    Arch Pathol Lab Med; 1989 Mar; 113(3):232-5. PubMed ID: 2493234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of non-A, non-B hepatitis in the United States.
    Alter MJ; Hadler SC; Francis DP; Maynard JE
    Prog Clin Biol Res; 1985; 182():71-9. PubMed ID: 3929264
    [No Abstract]   [Full Text] [Related]  

  • 16. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter?
    Vox Sang; 1983; 44(1):48-64. PubMed ID: 6402857
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
    Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
    N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transfusion non-A, non-B hepatitis in Finland: a prospective study.
    Lagerstedt A; Leikola J; Merikallio E; Ukkonen P
    Scand J Clin Lab Invest; 1982 Nov; 42(7):567-70. PubMed ID: 6818679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-hepatitis C (HCV) ELISA. A serologic test for non-A non-B hepatitis (NANBH) after blood transfusion].
    Orstavik I; Siebke JC; Rollag H; Skaug K; Størvold G; Orjasoeter H
    Tidsskr Nor Laegeforen; 1989 Dec; 109(34-36):3648. PubMed ID: 2515616
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical characteristics of non-A, non-B viral hepatitis in comparison with other types of viral hepatitis].
    Kikuchi K; Tateda A
    Nihon Rinsho; 1981 Oct; 39(10):3216-25. PubMed ID: 6803019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.